Hong Kong Stock Movement | Keymed Biosciences-B (02162.HK) once fell over 16%; recently announced global Phase III data for CLDN18.2 ADC CMG901

Zhitong Finance APP has learned that Keymed Biosciences-B (02162.HK) once fell more than 16%, and as of press time, it was down 13.77% at HK$69.85, with a turnover of HK$548 million.